Micheletto 1997.

Methods	Setting: Italy, hospital outpatient clinic Length of intervention period: 8 weeks Randomisation: yes, method not stated Allocation concealment: unclear Design: parallel group Masking: unclear Excluded: not stated Withdrawals: not stated Baseline characteristics: no details Jadad score: 1
Participants	32 adults Age range: not stated Inclusion criteria: Adult patients with stable asthma receiving inhaled BDP 1000 mcg/day No other details Exclusion criteria: Not stated
Interventions	BDP: 200 mcg 4xdaily (800 mcg/day) via Pulvinal DPI BUD: 200 mcg 4xdaily (800 mcg/day) via Turbuhaler DPI
Outcomes	FEV1 FVC Clinic PEFR FEF 25‐75 Morning PEFR Evening PEFR Daily beta2 agonist use Serum ECP Morning serum cortisol
Notes	Study in abstract form only. No reply from trial sponsors to clarify details of randomisation procedure, further inclusion/exclusion criteria, patient withdrawals or data for outcomes.
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	B ‐ Unclear